TWO SIGMA ADVISERS, LP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,163,720
-33.9%
370,500
-24.1%
0.01%
-33.3%
Q3 2022$3,272,000
+426.9%
488,300
+230.8%
0.01%
+350.0%
Q2 2022$621,000
+181.0%
147,600
+125.0%
0.00%
+100.0%
Q1 2022$221,000
-26.6%
65,600
-31.2%
0.00%0.0%
Q4 2021$301,000
+85.8%
95,400
+92.7%
0.00%
Q3 2021$162,000
-16.9%
49,500
+6.9%
0.00%
-100.0%
Q2 2021$195,000
-51.1%
46,300
-42.1%
0.00%0.0%
Q1 2021$399,000
-66.1%
80,000
-14.2%
0.00%
-66.7%
Q4 2020$1,178,000
+18.5%
93,200
-7.9%
0.00%0.0%
Q3 2020$994,000
-19.1%
101,200
-18.0%
0.00%
-25.0%
Q2 2020$1,228,000
+13.1%
123,392
+0.4%
0.00%0.0%
Q1 2020$1,086,000
+2.5%
122,900
+7.1%
0.00%
+100.0%
Q4 2019$1,059,000
+65.5%
114,800
+5.5%
0.00%0.0%
Q3 2019$640,000
-48.9%
108,800
+4.2%
0.00%
-33.3%
Q2 2019$1,253,000
+74.3%
104,400
+75.2%
0.00%
+50.0%
Q1 2019$719,000
-16.2%
59,600
-12.9%
0.00%0.0%
Q4 2018$858,000
-20.9%
68,400
-6.4%
0.00%
-33.3%
Q3 2018$1,085,000
-6.5%
73,100
+6.1%
0.00%0.0%
Q2 2018$1,160,000
+15.4%
68,900
+56.9%
0.00%0.0%
Q1 2018$1,005,000
-32.8%
43,900
-24.1%
0.00%
-25.0%
Q4 2017$1,496,000
+1178.6%
57,838
+398.6%
0.00%
Q3 2016$117,000
-41.2%
11,600
-34.5%
0.00%
-100.0%
Q2 2016$199,000
-11.2%
17,700
+7.9%
0.00%0.0%
Q1 2016$224,000
-46.0%
16,400
-40.1%
0.00%
-66.7%
Q1 2015$415,00027,4000.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
BVF INC/IL 2,253,000$7,097,0000.26%
INGALLS & SNYDER LLC 1,358,573$4,280,0000.19%
RA Capital Management 3,033,603$9,556,0000.17%
Kensington Investment Counsel, LLC 85,483$269,0000.16%
Perceptive Advisors 4,301,282$13,548,0000.10%
NewEdge Wealth, LLC 381,326$1,201,0000.05%
Black Diamond Financial, LLC 46,000$145,0000.05%
Birchview Capital, LP 20,000$63,0000.04%
XTX Topco Ltd 14,305$45,0000.02%
Alyeska Investment Group, L.P. 548,090$1,726,0000.02%
View complete list of CONCERT PHARMACEUTICALS INC shareholders